Windtree Therapeutics Inc (WINT)
4.49
+0.19
(+4.42%)
USD |
NASDAQ |
May 17, 16:00
4.41
-0.08
(-1.78%)
After-Hours: 20:00
Windtree Therapeutics Research and Development Expense (Annual): 8.341M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.341M |
| December 31, 2022 | 11.10M |
| December 31, 2021 | 17.79M |
| December 31, 2020 | 15.37M |
| December 31, 2019 | 12.69M |
| December 31, 2018 | 10.56M |
| December 31, 2017 | 17.38M |
| December 31, 2016 | 31.70M |
| December 31, 2015 | 28.89M |
| December 31, 2014 | 26.69M |
| December 31, 2013 | 27.66M |
| December 31, 2012 | 21.57M |
| December 31, 2011 | 17.23M |
| December 31, 2010 | 17.14M |
| Date | Value |
|---|---|
| December 31, 2009 | 19.08M |
| December 31, 2008 | 26.57M |
| December 31, 2007 | 26.20M |
| December 31, 2006 | 23.72M |
| December 31, 2005 | 24.14M |
| December 31, 2004 | 25.79M |
| December 31, 2003 | 19.75M |
| December 31, 2002 | 14.35M |
| December 31, 2001 | 8.007M |
| December 31, 2000 | 7.356M |
| December 31, 1999 | 2.869M |
| December 31, 1998 | 5.10M |
| December 31, 1997 | 4.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
8.341M
Minimum
2023
17.79M
Maximum
2021
13.06M
Average
12.69M
Median
2019
Research and Development Expense (Annual) Benchmarks
| Lexicon Pharmaceuticals Inc | 58.89M |
| AIM ImmunoTech Inc | 10.94M |
| Perspective Therapeutics Inc | 21.31M |
| Protalix BioTherapeutics Inc | 17.09M |
| Armata Pharmaceuticals Inc | 33.77M |